Feel Good, Inside and Out:
The Probiotic Partner for GLP-1 Medications

GLP-1 receptor agonists are transforming the landscape of weight management and diabetes treatment with their proven effectiveness. However, their rapid adoption has highlighted a significant challenge: gastrointestinal side effects. 

While these medications are highly effective, they can disrupt gut balance, causing symptoms such as nausea, bloating, altered bowel movements, and increased intestinal inflammation—factors that often hinder long-term adherence.

 ibSium^® is  a clinically validated, yeast-based probiotic designed to address these challenges. By alleviating intestinal side effects, restoring gut balance, and reducing diarrhea, ibSium^® offers GLP-1 users a natural support for their gut comfort. 

Experience the difference with ibSium^®—a solution that not only mitigates discomfort but also enhances overall digestive health.